[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357133-105":59,"doc-detail-357133-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancer-screening-and-cancer-prognosis-in-patients-with-alzheimer-disease-and-related-dementias","Breast cancer screening and cancer prognosis in patients with Alzheimer disease and related dementias","","Breast cancer screening is vital for early detection and improved survival in Alzheimer disease and related dementias (ADRD) patients, yet real-world evidence on survival and prognosis is limited. A retrospective cohort study used Surveillance, Epidemiology, and End Results–Medicare data (1999-2019) to assess effects of screening on cancer stage and survival in ADRD women aged 67+. Results showed screened patients had lower advanced-stage rates (22.2% vs 42.6%) and longer survival (65.9 vs 45.7 months), with higher odds and death hazard in unscreened patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-screening-and-cancer-prognosis-in-patients-with-alzheimer-disease-and-related-dementias/357133/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-screening-and-cancer-prognosis-in-patients-with-alzheimer-disease-and-related-dementias/357133.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What study design and data source were used to evaluate screening effects in ADRD patients?","Question",{"text":112,"@type":113},"A retrospective cohort study analyzed Surveillance, Epidemiology, and End Results–Medicare data from 1999 to 2019.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did breast cancer screening affect advanced-stage diagnosis and survival?",{"text":117,"@type":113},"Patients with at least one completed screening had significantly lower advanced-stage diagnosis rates (22.2% vs 42.6%) and longer survival (65.9 vs 45.7 months) than those with no screening history.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were reported to be statistically significant for diagnosis stage and survival?",{"text":121,"@type":113},"Comorbidities, age, and race were statistically significant predictors of both diagnosis stage and survival in breast cancer patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357133,1790187070,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","JNCI Cancer Spectrum, 2026, 10(2), pkag019  \n[https://doi.org/10.1093/jncics/pkag019](https://doi.org/10.1093/jncics/pkag019)  \nAdvance Access Publication Date: February 27, 2026  \nArticle  \nBreast cancer screening and cancer prognosis in patients with Alzheimer disease and related dementias  \nYushi Huang , PhD, PharmD1, Yongqiu Li, PhD1, Xiwei Lou, MS1, Jessica Y. Islam , PhD, MPH2, Muxuan Liang , PhD3, Thomas J. George , MD, FACP, FASCO4, Jiang Bian , PhD5,6, Yi Guo , PhD, FAMIA􀀃 ,1 ,3  \n1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States 2Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States  \n3Department of Biostatistics, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, FL, United States 4Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, United States  \n5Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, United States  \n6Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, United States  \n􀀃 Corresponding author: Yi Guo, PhD, FAMIA, Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States ([yiguo@ufl.edu](yiguo@ufl.edu)) .  \nAuthor Contributions: Drs Y Huang and Y Li contributed equally as co-first authors.  \nAbstract  \nBackground: Breast cancer screening is crucial for early detection and improved survival in Alzheimer disease and related dementias (ADRD) patients, but real-world evidence of its effects on survival and prognosis remains insufficient.  \nMethods: We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results–Medicare data (1999-2019) to analyze the impact of breast cancer screening on prognosis (ie, cancer stage) and survival in ADRD women with breast cancer diagnosed at ages 67 years and older. Logistic and Cox regression models were employed to assess the relationship between screening and risk of advanced stage at diagnosis and length of survival, adjusted for relevant covariates (eg, marital status, comorbidities, age at screening). Results: The cohort included 8739 ADRD patients with breast cancer, with 4483 completed at least 1 screening between their ADRD and first breast cancer diagnosis. The cohort completed screening had statistically significant lower rates of advanced-stage diagnosis (22.2% vs 42.6%) and longer survival (65.9 vs 45.7 months) compared with the cohort without any screening history. Unscreened patients had 2.7 times higher odds of advanced-stage diagnosis and 2 times higher hazard of death than patients with at least 1 screening completed before breast cancer diagnosis. Effects of comorbidities, age, and race were statistically significant on diagnosis stage and survival in breast cancer patients.  \nConclusion: Our study demonstrated the benefit of screening in early diagnosis and longer survival in ADRD patients with breast cancer, which advocates for an expansion of current breast cancer screening recommendations to more effectively guide cancer care for ADRD patients.  \nIntroduction  \nBreast cancer is the most commonly diagnosed cancer in females in the United States. According to the American Cancer Society (ACS), an estimated 287 850 new cases of invasive breast cancer were expected to be diagnosed in the United States in 2024. The highest incidence rate of diagnosis was among women aged 65- 74 years, at 245.3 per 100 000, followed by women aged older than 75 years, at 242.2 per 100 000.1 In the meantime, nearly all individuals with Alzheimer disease and related dementias (ADRD) are aged older than 65 years, and more than half (51 . 2%) are female.2 As of 2022, approximately 3.4 million women in the United States were living wi","cbCainWTSf5WfiWV","https://ap.wps.com/l/cbCainWTSf5WfiWV","pdf",945546,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What study design and data source were used to evaluate screening effects in ADRD patients?\",\"answer\":\"A retrospective cohort study analyzed Surveillance, Epidemiology, and End Results–Medicare data from 1999 to 2019.\"},{\"question\":\"How did breast cancer screening affect advanced-stage diagnosis and survival?\",\"answer\":\"Patients with at least one completed screening had significantly lower advanced-stage diagnosis rates (22.2% vs 42.6%) and longer survival (65.9 vs 45.7 months) than those with no screening history.\"},{\"question\":\"Which factors were reported to be statistically significant for diagnosis stage and survival?\",\"answer\":\"Comorbidities, age, and race were statistically significant predictors of both diagnosis stage and survival in breast cancer patients.\"}]","Breast cancer screening and cancer prognosis in patients with Alzheimer disease and related dementias | PDF",1790129101,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5b0c785443de69ba840f430b21fc6f2.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/316296544755885bef9f9ee578fc2901.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b76a64d85023d25e760a3475e37c3b95.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e753e1909dc6eba7242a936d5bcfba47.webp",980,1287]